Is QRFPR p.Arg22Gln (c.65G>A) pathogenic?

QRFPR p.Arg22Gln (c.65G>A) is classified Uncertain significance in QRFPR (ClinVar, Single submitter, 1 submitter; last evaluated 2025-02-11). AlphaMissense: likely benign (0.295); Rare (popmax 0.176%, afr).

How common is QRFPR p.Arg22Gln (c.65G>A) in the general population?

QRFPR p.Arg22Gln (c.65G>A) is rare (popmax 0.176%, afr) (gnomAD).

What do computational predictors say about QRFPR p.Arg22Gln (c.65G>A)?

AlphaMissense predicts likely benign (score 0.295) — an in-silico prediction, not a clinical call.

QRFPR p.Arg22Gln

c.65G>A · VCV3785828

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.295 · ACMG-weighted

gnomAD v4.1

Rare

rare (popmax 0.176%, afr)

Missense predictors

0/2 damaging

AlphaMissense, SaProt · REVEL indeterminate

Computational evidence

Protein change
AlphaMissense	0.295	likely benign
REVEL	0.331	indeterminate
SaProt	LLR -8.98	tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 4.6	GERP 1.6, phastCons 1
Regional constraint	o/e 1.02	unconstrained · MANE · 51 kb · p 0.68 · regional, not allelic
Overall
CADD	26.4	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.176% African / African-American · 132/74,894 alleles

Filtering AF 0.152% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.143%

Overall 0.0094% 151/1,606,802 alleles · rare exomes 76/1,454,486 · genomes 75/152,316 · joint denominator

Ancestry group	Frequency	1 in
African / African-Americangrpmax	0.176%	567
Remaining individualsnot grpmax-eligible	0.0145%	6,898
Admixed American	0.0118%	8,476
South Asian	0.00111%	90,296
European (non-Finnish)	0.00017%	588,024

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: QRFPR
Protein: p.Arg22Gln
Coding: c.65G>A
MANE Select: NM_198179
Type: single nucleotide variant
Location: chr4:121380583 (GRCh38)
Gene constraint: LOEUF 1.532 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 78.74 · 2 PDB

Full QRFPR gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

QRFPR p.Ile296Thr Uncertain significance ★★ ⚠ same type
QRFPR p.Ala128Thr Uncertain significance ★ ⚠ same type
QRFPR p.Ala315Val Uncertain significance ★ ⚠ same type
QRFPR p.Arg13Trp Uncertain significance ★ ⚠ same type
QRFPR p.Arg160Gln Uncertain significance ★ ⚠ same type
QRFPR p.Arg161Thr Uncertain significance ★ ⚠ same type
QRFPR p.Arg16Pro Uncertain significance ★ same type
QRFPR p.Asn110Asp Uncertain significance ★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/qrfpr-p-arg22gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown